Thermo Fisher Commercial Tutorial

Recent developments in genome editing and cell engineering technologies, particularly the advent of CRISPR Cas9 technology, has truly democratized the field and has unprecedented potential in the study of functional genomics, target identification and gene therapy. This presentation will provide an overview of the genome editing and cell engineering workflow and highlight the use of flow cytometry to both expedite and augment the workflow, while enabling a more in depth and meaningful analysis of engineered cells.